SCHEDULE: ADIA Discloses 5.9% Stake in Medline Inc.

Abu Dhabi Investment Authority and its subsidiary Platinum Falcon B 2018 RSC Limited have disclosed a combined 5.9% beneficial ownership in Medline Inc.'s Class A Common Stock.

Summary

• Abu Dhabi Investment Authority (ADIA) and its wholly-owned subsidiary, Platinum Falcon B 2018 RSC Limited, have filed a Schedule 13G disclosing their beneficial ownership in Medline Inc.
• ADIA beneficially owns an aggregate of 47,515,277 shares of Medline Inc.'s Class A Common Stock, representing 5.9% of the class.
• Platinum Falcon B 2018 RSC Limited directly owns 46,998,036 shares, which constitutes 5.8% of the class, and ADIA is deemed a beneficial owner of these shares.
• The ownership calculation is based on 811,418,179 shares of Class A Common Stock outstanding as of December 18, 2025.
• ADIA holds sole voting and dispositive power over 517,241 shares, and shared voting and dispositive power over 46,998,036 shares.
• Platinum Falcon holds shared voting and dispositive power over 46,998,036 shares, with no sole voting or dispositive power.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as the disclosure of a significant beneficial ownership by a major sovereign wealth fund like ADIA can be interpreted as a vote of confidence in Medline Inc.'s long-term prospects and stability.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that the disclosure of a significant stake by a sovereign wealth fund like ADIA in a healthcare company like Medline Inc. underscores continued institutional interest in the healthcare sector, particularly in established players. This type of investment can signal long-term confidence in the company's market position and the broader industry's stability.

Stakeholder Impact

• Shareholders: Increased institutional ownership by a major sovereign wealth fund may be perceived as a positive signal, potentially enhancing investor confidence and market stability for Medline Inc.'s stock.

Key Dates

Recommendation

The Schedule 13G filing indicates a significant beneficial ownership by a reputable sovereign wealth fund, Abu Dhabi Investment Authority, in Medline Inc. This signals institutional confidence in the company. However, as this filing is purely a disclosure of an existing stake and does not provide new operational or financial performance data, a 'hold' recommendation is appropriate for existing investors, while potential investors should conduct further due diligence on Medline Inc.'s fundamentals.

Keywords

Medline Inc., Class A Common Stock, Abu Dhabi Investment Authority, Platinum Falcon B 2018 RSC Limited, Schedule 13G, Beneficial Ownership, Institutional Investor, Healthcare